Vaxxinity, Inc.
VAXX · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $108,135 | $173,629 | $318,733 | $286,158 |
| - Cash | $4,931 | $17,395 | $37,058 | $22,585 |
| + Debt | $15,168 | $13,308 | $13,731 | $13,986 |
| Enterprise Value | $118,372 | $169,542 | $295,406 | $277,559 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$456 | -$666 | -$512 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10,754 | -$12,303 | -$13,305 | -$17,643 |
| % Margin | – | – | – | – |
| Net Income | -$11,392 | -$13,145 | -$13,977 | -$18,421 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.09 | -0.1 | -0.11 | -0.15 |
| % Growth | 10.1% | 9.1% | 26.7% | – |
| Operating Cash Flow | -$11,845 | -$13,184 | -$12,158 | -$20,051 |
| Capital Expenditures | -$414 | -$127 | -$90 | -$172 |
| Free Cash Flow | -$12,259 | -$13,311 | -$12,248 | -$20,223 |